XJB-5-131

XJB-5-131 has been studied in 2 papers since 2018: none in people yet, 1 in animals, 1 in cells. The research so far is in animals and cells. The newest paper, Apr 12, 2025: “Attenuation of Cellular Senescence and Improvement of Osteogenic Differentiation Capacity of Human Liver Stem Cells Using Specific Senomorphic and Senolytic Agents”.

Intervention

2 papers study it6 findingsUpdated

PubChemChEBIMeSH

None of its findings points the other way.

  • 2 independent labs in 1 country
  • Funders: National Institute on Aging and others
  • 3 of 6 findings with company ties
  • Animals1
  • Cells1

What did studies of XJB-5-131 find?

5

Studies of XJB-5-131 measured 5 outcomes; the most studied are cellular senescence (2 studies), stem cell differentiation (1) and senescence-associated secretory phenotype (SASP) (1).

Cellular senescence

downin human cells1downin mice1

2 studies
  1. XJB-5-131 decreases cellular senescence in human cells.

    “chronic treatment with the senomorphic XJB-5-131 or the senolytics cocktail D + Q reduced the number of senescent cells”

    Cellsexpansion in culturesenomorphicliver

    Attenuation of Cellular Senescence and Improvement of Osteogenic Differentiation Capacity of Human Liver Stem Cells Using Specific Senomorphic and Senolytic Agents

    Stem cell reviews and reports

  2. XJB-5-131 decreases cellular senescence in mice.

    “Chronic treatment of Ercc1-/∆ mice with the mitochondrial-targeted radical scavenger XJB-5-131 attenuated oxidative DNA damage, senescence and age-related pathology.”

    AnimalsErcc1-/∆ mice

    Spontaneous DNA damage to the nuclear genome promotes senescence, redox imbalance and aging

    Redox biology

More on Cellular senescence

Stem cell differentiation

upin human cells1

1 study
  1. XJB-5-131 improves stem cell differentiation in human cells.

    “treatment with XJB-5-131 and D + Q improved the capacity of HLSCs to undergo osteogenic differentiation following extensive in vitro expansion”

    Cellsfollowing extensive in vitro expansionliver

    Attenuation of Cellular Senescence and Improvement of Osteogenic Differentiation Capacity of Human Liver Stem Cells Using Specific Senomorphic and Senolytic Agents

    Stem cell reviews and reports

More on Stem cell differentiation

Senescence-associated secretory phenotype (SASP)

downin human cells1

1 study
  1. XJB-5-131 decreases senescence-associated secretory phenotype (SASP) in human cells.

    “significantly reduced the expression of senescence-associated genes and several inflammatory SASP factors in later passage HLSCs”

    Cellsin later passage HLSCssenomorphicliver

    Attenuation of Cellular Senescence and Improvement of Osteogenic Differentiation Capacity of Human Liver Stem Cells Using Specific Senomorphic and Senolytic Agents

    Stem cell reviews and reports

More on Senescence-associated secretory phenotype (SASP)

Age-related pathology

downin mice1

1 study
  1. XJB-5-131 decreases age-related pathology in mice.

    “Chronic treatment of Ercc1-/∆ mice with the mitochondrial-targeted radical scavenger XJB-5-131 attenuated oxidative DNA damage, senescence and age-related pathology.”

    AnimalsErcc1-/∆ mice

    Spontaneous DNA damage to the nuclear genome promotes senescence, redox imbalance and aging

    Redox biology

Oxidative DNA damage

downin mice1

1 study
  1. XJB-5-131 decreases oxidative DNA damage in mice.

    “Chronic treatment of Ercc1-/∆ mice with the mitochondrial-targeted radical scavenger XJB-5-131 attenuated oxidative DNA damage, senescence and age-related pathology.”

    AnimalsErcc1-/∆ mice

    Spontaneous DNA damage to the nuclear genome promotes senescence, redox imbalance and aging

    Redox biology

More on Oxidative DNA damage

Latest